Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths.
Vitamin D may potentially play a central role in glucose homeostasis and β-cell function (BCF), although studies are not consistent. Aim of our study was to test the hypotheses of a direct relationship between vitamin D, insulin sensitivity (IS) and BCF in overweight and obese non-diabetic children. Cross-sectional study carried out at the Childhood Obesity Outpatient Clinic, University Hospital of Verona. 122 Caucasian overweight and obese children (age: 12.8±0.2years) were enrolled. genetic or endocrine causes of obesity; chronic diseases or therapies. Patients underwent oral glucose tolerance test. HOMA-IR, Matsuda-index, Insulinogenic-index were calculated. BCF was reconstructed by mathematical modeling and described by Derivative and Proportional Control. Total 25-hydroxyvitamin D and vitamin D-binding protein (VDBP) were measured. Two SNPs (rs4588 and rs7041) in the VDBP gene were studied, and bioavailable-vitamin D (BVD) was calculated. Hypovitaminosis D was documented in 90% of patients. Forty-seven subjects were homozygous for both SNPs. Total vitamin D was positively correlated with Matsuda-index (p=0.002), VDBP (p=0.045), and negatively with BMI SDS (p=0.043), HOMA-IR (p=0.008), HOMA-B (p=0.001), IGI (p=0.007), Derivative Control (p=0.036) and Proportional Control (p=0.018). Total vitamin D, adjusted for age, gender, BMI SDS, puberty, seasonality of vitamin D measurement, was a predictor of Matsuda-index, HOMA-IR, HOMA-B, IGI, Proportional Control (all p<0.05). BVD was positively correlated with total vitamin D (p<0.001) and negatively with BMI SDS (p=0.041). Hypovitaminosis D negatively influences BCF and IS, suggesting that vitamin D levels might be implicated in glucose metabolism impairment in overweight and obese individuals.